+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 4115 Pages
  • Global
From
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 1834 Pages
  • Global
From
Interstitial Cystitis Market Report 2025 - Product Thumbnail Image

Interstitial Cystitis Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Gene Therapy Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Gene Therapy Collaboration and Licensing Deals 2016-2025

  • Report
  • May 2025
  • 450 Pages
  • Global
From
Primary Immunodeficiency Disorders - Global Strategic Business Report - Product Thumbnail Image

Primary Immunodeficiency Disorders - Global Strategic Business Report

  • Report
  • September 2025
  • 280 Pages
  • Global
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pruritus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pruritus Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 192 Pages
  • Global
From
Toxoid Vaccines - Global Strategic Business Report - Product Thumbnail Image

Toxoid Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 282 Pages
  • Global
From
Live Attenuated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Live Attenuated Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 563 Pages
  • Global
From
Cholera Vaccines - Global Strategic Business Report - Product Thumbnail Image

Cholera Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 367 Pages
  • Global
From
DNA Vaccines - Global Strategic Business Report - Product Thumbnail Image

DNA Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 171 Pages
  • Global
From
Bacterial Vaccines - Global Strategic Business Report - Product Thumbnail Image

Bacterial Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 490 Pages
  • Global
From
Polio Vaccines - Global Strategic Business Report - Product Thumbnail Image

Polio Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 277 Pages
  • Global
From
Inactivated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 468 Pages
  • Global
From
Tetanus Toxoid Vaccine - Global Strategic Business Report - Product Thumbnail Image

Tetanus Toxoid Vaccine - Global Strategic Business Report

  • Report
  • September 2025
  • 265 Pages
  • Global
From
Dermatological Drugs - Global Strategic Business Report - Product Thumbnail Image

Dermatological Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Optic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Optic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 62 Pages
  • Global
From
Mesenchymal Stem Cells Market - Global Forecast 2025-2030 - Product Thumbnail Image

Mesenchymal Stem Cells Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Pruritus Therapeutics Market Size, Share & Trends Analysis Report by Disease (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria), Product (Corticosteroids, Antihistamines), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Thumbnail Image

Pruritus Therapeutics Market Size, Share & Trends Analysis Report by Disease (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria), Product (Corticosteroids, Antihistamines), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • February 2025
  • 100 Pages
  • Global
From
Prostate Health - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Prostate Health - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 119 Pages
  • Global
From
Loading Indicator